# To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

> **NCT00946504** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 28 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)
- **DRUG:** Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)

## Key facts

- **NCT ID:** NCT00946504
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-10
- **Primary completion:** 1992-10
- **Final completion:** 1992-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946504, "To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00946504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*